Phone: (605) 357-1508
The Guo lab's research is focused on the development of therapeutic approaches to treating type 1 diabetes.
Citations listed below are presented in a standardized, modified format for display purposes only. They do not necessarily reflect the preferred style and conventions of the faculty member or discipline.
- Xia, X, Liu, Y, Liao, Y, Guo, Zhiguang, Huang, C, Zhang, F, Jiang, L, Wang, Xuejun, Liu, Jing, and Huang, H. Synergistic effects of gefitinib and thalidomide treatment on EGFR-TKI-sensitive and -resistant NSCLC., 172409. European Journal of Pharmacology, 2019. (DOI: 10.1016/j.ejphar.2019.172409)